Describing deprescribing trials better: an elaboration of the CONSORT statement

Journal article

Objective
The objective of this study was to identify key features to be addressed in the reporting of deprescribing trials and to elaborate and explain CONSORT items in this regard.
Study Design and Setting
As a first step in a multistage process and based on a systematic review of deprescribing trials, we elaborated variation in design, intervention, and reporting of the included trials of the review. We identified items that were missed or ... Expand abstract

Authors: Blom, JW; Muth, C; Glasziou, P; McCormack, JP; Perera, R

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Elsevier Publisher's website
• Journal: Journal of Clinical Epidemiology Journal website
• Volume: 127
• Pages: 87-95
• Publication date: 2020-07-21
• Acceptance date: 2020-07-09
• DOI: 10.1016/j.jclinepi.2020.07.011
• EISSN: 1878-5921
• ISSN: 0895-4356
• Pmid: 32707072
• Language: English
• Keywords: drug-related side effects and adverse reactions; research design; placebos; reporting guidelines; primary care; equivalence trials as topic; delphi technique; FFR; research report; study design; randomized controlled trials as topic; randomized controlled trial; CONSORT statement; deprescriptions; guidelines as topic; checklist; humans; deprescribing